J&J Is Spitzer's Next Target: New York AG Opens Broad Off-Label Promotion Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Procrit, Risperdal and four other leading J&J pharmaceutical brands are the subject of a document request from New York Attorney General Eliot Spitzer. J&J is already facing two federal investigations into marketing practices.